// App-Quantinova.ai

81 : Multicenter Total Therapy Gimema LAL 1509 Protocol for De Novo Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Updated Results and Refined Genetic-Based Prognostic Stratification

Researchers

Presenter

  • Sabina Chiaretti

Principal Investigators

  • Antonella Vitale

  • Loredana Elia

  • Giovanni Martinelli

  • Francesca Ronco

  • Lidia Edwige Santoro

  • Anna Lucia Fedullo

  • Silvana Albino

  • Alfonso Piciocchi

  • Paola Fazi

  • Francesco Di Raimondo

  • Antonella Fornaro

  • Francesco Fabbiano

  • Alfonso Maria -Arco

Medical Centers

  • Hematology and Cellular Therapy, Ospedale Mazzoni, Ascoli Piceno, Italy

  • Institute of Hematology, Catholic University, Rome, Italy

  • Division of Hematology 1, IRCCS A.O.U. San Martino IST, Genova, Genova, Italy

  • hematology, azienda ospedaliera bianchi-melacrino-morelli, reggio calabria, Italy

  • Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy

  • Department of Biomedical Sciences, Division of Hematology, Ospedale Ferrarotto, University of Catania, Italy, Catania, Italy

  • Division of Hematology, Niguarda Ca Granda Hospital, Milan, Italy

  • Hematology and BMT Unit, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy

  • Hematology, Vito Fazzi Hospital, Lecce, Italy

  • Division of Onco-hematology Ospedale Umberto I - Nocera Inferiore (SA), Nocera Inferiore, Italy

  • Division of Hematology -Azienda Ospedaliera S.G.Moscati, Avellino, Italy, Avellino, Italy

  • Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy, Palermo, Italy

  • Gimema Data Center, Rome, Italy

  • Department of Hematology, Ospedale Civile dello Spirito Santo - Pescara, Pescara, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Abelson murine leukemia viral oncogene homolog

  • Breakpoint Cluster Region

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Clofarabine

  • dasatinib

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final